Stockscreener 앱 받기
66.39
2.04%
1.33
시간 외 거래:
66.60
0.21
+0.32%
Bridgebio Pharma Inc 주식(BBIO)의 최신 뉴스
(BBIO) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
What moving averages say about BridgeBio Pharma Inc.Market Growth Report & Fast Gain Stock Tips - newser.com
How dovish Fed policy supports BridgeBio Pharma Inc. (2CL) stock2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com
Why BridgeBio Pharma Inc. (2CL) stock stays resilientWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
What drives BridgeBio Pharma Inc stock priceDividend Aristocrats List & Fast Growing Portfolio Trading - earlytimes.in
What indicators show strength in BridgeBio Pharma Inc.2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
How BridgeBio Pharma Inc. stock performs in stagflationWeekly Risk Report & Consistent Income Trade Recommendations - newser.com
Analysts Conflicted on These Healthcare Names: Incyte (INCY), Wave Life Sciences (WVE) and BridgeBio Pharma (BBIO) - The Globe and Mail
BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge - Yahoo Finance
Wells Fargo Maintains BridgeBio Pharma (BBIO) Overweight Recommendation - Nasdaq
BridgeBio Pharma (BBIO): Wells Fargo Raises Price Target to $84 - GuruFocus
BridgeBio Pharma CEO Kumar Neil sells $5m in shares By Investing.com - Investing.com Australia
BridgeBio Pharma CEO Kumar Neil sells $5m in shares - Investing.com
Bridgebio Pharma Insider Sold Shares Worth $4,983,111, According to a Recent SEC Filing - MarketScreener
Pfizer’s Advertising Challenge Against BridgeBio’s Attruby Leverages US FDA Untitled Letter - Citeline News & Insights
Sustained drop in all-cause mortality observed with BridgeBio’s acoramidis - The Pharma Letter
BridgeBio Pharma Insider Sold Shares Worth $3,888,999, According to a Recent SEC Filing - MarketScreener
Can machine learning forecast BridgeBio Pharma Inc. recoveryTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
Analyzing BridgeBio Pharma Inc. with risk reward ratio chartsTrade Risk Assessment & AI Powered Market Entry Ideas - newser.com
BridgeBio Pharma’s Global Expansion Shockwave: Why Investors Are Buzzing! - Smartkarma
BridgeBio (BBIO) Reports Promising Data for Acoramidis in Cardia - GuruFocus
BridgeBio presents data from ATTRibute-CM study on acoramidis - TipRanks
BridgeBio Pharma Reports Significant All-Cause Mortality Reductions with Acoramidis in Variant ATTR-CM Patients at AHA Scientific Sessions 2025 - Quiver Quantitative
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations - GlobeNewswire
Using Bollinger Bands to evaluate BridgeBio Pharma Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
JP Morgan Raises Price Target for BBIO, Maintains Overweight Rat - GuruFocus
BridgeBio Pharma Director Makes a Multi-Million Dollar Stock Move! - TipRanks
BridgeBio Pharma Director Ronald J Daniels Sells Over $3.8 Million in Company Stock - TradingView
Long term debt to total equity ratio of BridgeBio Pharma, Inc. – HAM:2CL - TradingView
[Form 4] BridgeBio Pharma, Inc. Insider Trading Activity - Stock Titan
National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry - The Manila Times
Will BridgeBio Pharma Inc. stock pay special dividendsDay Trade & Daily Profit Focused Screening - newser.com
BridgeBio Pharma, Inc. (BBIO) Stock Forecasts - Yahoo! Finance Canada
CapEx per share of BridgeBio Pharma, Inc. – MIL:1BBIO - TradingView
BridgeBio Pharma: A High-Stakes Biotech Investment - AD HOC NEWS
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ceribell, Inc. (CBLL), American Well (AMWL) and BridgeBio Pharma (BBIO) - The Globe and Mail
How BridgeBio Pharma Inc. (2CL) stock reacts to fiscal policiesWeekly Trend Recap & Reliable Price Breakout Signals - newser.com
Why retail investors favor BridgeBio Pharma Inc. stockJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com
Real time alert setup for BridgeBio Pharma Inc. performance2025 Key Lessons & Free Accurate Trade Setup Notifications - newser.com
Is BridgeBio Pharma Inc. stock a buy in volatile markets2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - fcp.pa.gov.br
BridgeBio Pharma Inc (BBIO) Stock Price, Trades & News - GuruFocus
13,856 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by Bryce Point Capital LLC - MarketBeat
1.43%
0.07%
자본화:
|
볼륨(24시간):